scholarly article | Q13442814 |
P2093 | author name string | Yun Wang | |
Zhiwen Chen | |||
Jin Yang | |||
Jie Song | |||
Zhiping Cai | |||
Guoning Guo | |||
Yaqin Huang | |||
Yuchao Li | |||
Qiangguo Gao | |||
P2860 | cites work | EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway | Q38966467 |
Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by PI3K/AKT signaling pathway | Q39016174 | ||
Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity | Q39344502 | ||
Diagnosis value of serum B7-H3 expression in non-small cell lung cancer | Q39875733 | ||
Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression | Q40131356 | ||
The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion | Q40606997 | ||
Upregulation of the B7/CD28 family member B7-H3 in bladder cancer | Q41851335 | ||
Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder. | Q53086009 | ||
T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival | Q81735740 | ||
The regulation of MMP targeting to invadopodia during cancer metastasis | Q21131317 | ||
B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production | Q24290870 | ||
A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints | Q26738729 | ||
Comprehensive molecular characterization of urothelial bladder carcinoma | Q28306864 | ||
Cancer statistics, 2016 | Q29547383 | ||
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer | Q29617772 | ||
Cancer immunotherapy comes of age | Q29619918 | ||
Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer | Q33520828 | ||
Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis | Q33788244 | ||
Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma | Q33892988 | ||
Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. | Q34294986 | ||
B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction | Q34298906 | ||
Overexpressed DNA polymerase iota regulated by JNK/c-Jun contributes to hypermutagenesis in bladder cancer | Q34902441 | ||
Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma | Q35032331 | ||
B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway | Q35530644 | ||
B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma | Q37140050 | ||
B7-H3 and its relevance in cancer; immunological and non-immunological perspectives | Q37881559 | ||
B7-H3-mediated tumor immunology: Friend or foe? | Q38135281 | ||
Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis | Q38547173 | ||
Immune checkpoint inhibitors: a new frontier in bladder cancer | Q38612706 | ||
Checkpoint inhibitors in bladder and renal cancers: results and perspectives. | Q38643514 | ||
RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway | Q38952177 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell migration | Q189092 |
bladder cancer | Q504775 | ||
P304 | page(s) | 816-824 | |
P577 | publication date | 2017-02-25 | |
P1433 | published in | Journal of Cancer | Q6294901 |
P1476 | title | B7-H3 Promotes the Migration and Invasion of Human Bladder Cancer Cells via the PI3K/Akt/STAT3 Signaling Pathway | |
P478 | volume | 8 |
Q91830459 | B7-H3 Induces Ovarian Cancer Drugs Resistance Through An PI3K/AKT/BCL-2 Signaling Pathway |
Q90636502 | B7-H3 Regulates Glioma Growth and Cell Invasion Through a JAK2/STAT3/Slug-Dependent Signaling Pathway |
Q47233613 | B7-H3 in tumors: friend or foe for tumor immunity? |
Q92512125 | B7-H3 increases the radioresistance of gastric cancer cells through regulating baseline levels of cell autophagy |
Q92889930 | B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression |
Q92209170 | Checkpoint Genes at the Cancer Side of the Immunological Synapse in Bladder Cancer |
Q45914413 | DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway. |
Q38631037 | Dermokine contributes to epithelial-mesenchymal transition through increased activation of signal transducer and activator of transcription 3 in pancreatic cancer |
Q38695460 | Effects of 17-allylamino-17-demethoxygeldanamycin on the induction of apoptosis and cell cycle arrest in HCT-116 cells |
Q57471232 | Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism |
Q54985778 | Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer. |
Q90468370 | Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma |
Q92237885 | Nobiletin Inhibits Cell Viability via the SRC/AKT/STAT3/YY1AP1 Pathway in Human Renal Carcinoma Cells |
Q92421585 | Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis |
Q58697139 | Targeting immunotherapy for bladder cancer using anti-CD3× B7-H3 bispecific antibody |
Q47328865 | The role and mechanism of β‑arrestins in cancer invasion and metastasis (Review). |
Search more.